Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Equity (2022 - 2026)

Centessa Pharmaceuticals has reported Return on Equity over the past 4 years, most recently at 0.0% for Q4 2025.

  • Quarterly Return on Equity changed 0.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Equity was 0.0% for Q4 2025 at Centessa Pharmaceuticals, up from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q3 2024 and troughed at 0.01% in Q3 2025.
  • The 4-year median for Return on Equity is 0.01% (2023), against an average of 0.01%.
  • The largest YoY upside for Return on Equity was 0bps in 2023 against a maximum downside of 0bps in 2023.
  • A 4-year view of Return on Equity shows it stood at 0.01% in 2022, then grew by 0bps to 0.01% in 2023, then increased by 14bps to 0.01% in 2024, then rose by 9bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Return on Equity are 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).